TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas - PubMed (original) (raw)

Affiliations

• PMID: 1532241

TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas

A Greco et al. Oncogene. 1992 Feb.

Abstract

We have recently reported the frequent activation of the TRK oncogene in human papillary thyroid carcinoma. In this paper we describe the isolation and characterization of one of the thyroid TRK oncogenes, designated TRK-T1. A 1746-bp-long cDNA was isolated from a library derived from a primary transformant. The cDNA was able to induce foci in NIH3T3 cells. Sequence analysis revealed that TRK-T1 is created by an intrachromosomal rearrangement that juxtaposes the 5' end of the TPR gene to the TRK tyrosine kinase domain. The resulting hybrid mRNA contains 598 nucleotides of the TPR gene and 1148 nucleotides of the TRK proto-oncogene. TRK-T1 mRNA encodes a protein of 55 kDa reacting with antibodies against the carboxy terminus of the proto-TRK protein. We show also the involvement of TPR in the generation of another TRK-T oncogene.

PubMed Disclaimer

Similar articles

• The trk family of oncogenes and neurotrophin receptors.
  Lamballe F, Klein R, Barbacid M. Lamballe F, et al. Princess Takamatsu Symp. 1991;22:153-70. Princess Takamatsu Symp. 1991. PMID: 1844238 Review.
• Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
  Greco A, Miranda C, Pagliardini S, Fusetti L, Bongarzone I, Pierotti MA. Greco A, et al. Genes Chromosomes Cancer. 1997 Jun;19(2):112-23. Genes Chromosomes Cancer. 1997. PMID: 9172002
• The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
  Russell JP, Powell DJ, Cunnane M, Greco A, Portella G, Santoro M, Fusco A, Rothstein JL. Russell JP, et al. Oncogene. 2000 Nov 23;19(50):5729-35. doi: 10.1038/sj.onc.1203922. Oncogene. 2000. PMID: 11126359
• Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
  Albor A, Thraves PJ, Dritschilo A, Notario V. Albor A, et al. Oncogene. 1996 Oct 17;13(8):1755-63. Oncogene. 1996. PMID: 8895522
• Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
  Greco A, Miranda C, Pierotti MA. Greco A, et al. Mol Cell Endocrinol. 2010 May 28;321(1):44-9. doi: 10.1016/j.mce.2009.10.009. Epub 2009 Oct 31. Mol Cell Endocrinol. 2010. PMID: 19883730 Review.

Cited by

• Role of STAT3 in in vitro transformation triggered by TRK oncogenes.
  Miranda C, Fumagalli T, Anania MC, Vizioli MG, Pagliardini S, Pierotti MA, Greco A. Miranda C, et al. PLoS One. 2010 Mar 3;5(3):e9446. doi: 10.1371/journal.pone.0009446. PLoS One. 2010. PMID: 20209132 Free PMC article.
• The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
  Greco A, Mariani C, Miranda C, Lupas A, Pagliardini S, Pomati M, Pierotti MA. Greco A, et al. Mol Cell Biol. 1995 Nov;15(11):6118-27. doi: 10.1128/MCB.15.11.6118. Mol Cell Biol. 1995. PMID: 7565764 Free PMC article.
• Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.
  Rodrigues GA, Park M. Rodrigues GA, et al. Mol Cell Biol. 1993 Nov;13(11):6711-22. doi: 10.1128/mcb.13.11.6711-6722.1993. Mol Cell Biol. 1993. PMID: 8413267 Free PMC article.
• BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines.
  Leboeuf R, Baumgartner JE, Benezra M, Malaguarnera R, Solit D, Pratilas CA, Rosen N, Knauf JA, Fagin JA. Leboeuf R, et al. J Clin Endocrinol Metab. 2008 Jun;93(6):2194-201. doi: 10.1210/jc.2007-2825. Epub 2008 Apr 1. J Clin Endocrinol Metab. 2008. PMID: 18381570 Free PMC article.
• Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.
  Jiang T, Wang G, Liu Y, Feng L, Wang M, Liu J, Chen Y, Ouyang L. Jiang T, et al. Acta Pharm Sin B. 2021 Feb;11(2):355-372. doi: 10.1016/j.apsb.2020.05.004. Epub 2020 May 23. Acta Pharm Sin B. 2021. PMID: 33643817 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource